CREB1 and neoplasm: Unexpectedly, these analyses revealed that CREB target genes represent a significant proportion of the TTP-low tumor gene signature, suggesting that manipulating activity of the CREB pathway is a potential treatment option for patients with low TTP expressing tumors.